|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Neurobiology, Yale University, P.O. Box 208001, New Haven, Connecticut, 06520-8001, United States; Institute of Biophysics, National Research Council, Palermo, PA, Italy
2 Institute of Biophysics, National Research Council, Palermo, PA, Italy
3 Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States; Department of Opthamology, Louisiana State University Health Sciences Center, 2020 Gravier St Suite B, New Orleans, Louisiana, 70112, United States
* To whom correspondence should be addressed. E-mail: michele.migliore{at}pa.ibf.cnr.it.
Midbrain dopaminergic neurons are involved in several critical brain functions controlling goal-directed behaviors, reinforcing/reward processes, and motivation. Their dysfunctions alter dopamine release, and contribute to a vast range of neural disorders, from Parkinsonss disease to schizophrenia and addictive behaviors. These neurons have thus been a natural target of pharmacological treatments trying to ameliorate the consequences of several neuropathologies. From this point of view, a clear experimental link has been recently established between the increase in the pacemaker frequency of dopaminergic neurons in vitro after acute ethanol application, and a particular ionic current (Ih). The functional consequences in vivo, however, are not clear, and they are very difficult to explore experimentally. Here we use a realistic computational model of dopaminergic neurons in vivo to suggest that ethanol, through its effects on Ih, modifies the temporal structure of the spiking activity. The model predicts that the dopamine level may increase much more during bursting than pacemaking activity, especially in those brain regions with a slow dopamine clearance rate. The models suggests that a selective pharmacological remedy could thus be devised against the rewarding effects of ethanol that are postulated to mediate alcohol abuse and addiction, targeting the specific HCN genes expressed in dopaminergic neurons.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |